Hrt Financial LP Silverback Therapeutics, Inc. Transaction History

Hrt Financial LP

  • $18.1 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
BUY
N/A
135,684 New
135,684 $883,000
Q1 2022

May 16, 2022
SELL
$3.51 - $6.74 $223,193 - $428,583
-63,588 Closed
0 $0
Q4 2021

Feb 14, 2022
BUY
$6.03 - $11.67 $226,450 - $438,255
37,554 Added 144.25%
63,588 $423,000
Q3 2021

Nov 15, 2021
BUY
$9.98 - $35.22 $259,819 - $916,917
26,034 New
26,034 $259,000

Others Institutions Holding SBTX

# of Institutions
163
Shares Held
62.7M
Call Options Held
872K
Put Options Held
589K
View Full List

About Silverback Therapeutics, Inc.

SBTX Quotes by TradingView
  • Ticker SBTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 35,473,800
  • Description
  • Silverback Therapeutics, Inc., a biopharmaceutical company, develops tissue-targeted therapeutics for the treatment of chronic viral infections, cancer, and other serious diseases. The company offers SBT8230 to treat chronic hepatitis B virus infection by eliciting an anti-viral immune response by targeting TLR8 activation to the liver. Silverba...
More about SBTX
Track This Portfolio

Track Hrt Financial LP Portfolio

Follow Hrt Financial LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

News

Stay updated on Hrt Financial LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email